Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Keratosis, Actinic × 3-ingenyl angelate × Clear all

Phase

Phase 3 11 Phase 2 9 Phase 1 7 Phase 4 6 Phase NA 2 Phase EARLY_PHASE1 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 1

Interventions

LEO 43204 2 methyl 5-aminolevulinate 1 Photochemotherapy 1 Gels 1 Fluorouracil 1 AVX001 1 5-aminolevulinic acid hexyl ester 1 3-ingenyl angelate 1 1-phenyl-3,3-dimethyltriazene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01803477 2025-02-24

Safety and Dose Finding Study of New Vehicle Formulations Containing Ingenol Mebutate to Treat Actinic Keratosis on the Forearm

LEO Pharma

Phase 1/2 Completed

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡